The Citi and Alphabet-backed real estate platform hauled in $100m in series D equity and $263m in debt.

Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

The GV-backed candidate checking platform developer is fuelling its growth with fresh capital from FMR and stalwart investor T Rowe Price.

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Osage University Partners.

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Capital One and CrowdStrike.

Xerox’s newly formed augmented reality software business has been valued at $700m through an investment by ServiceNow.

Humane aims to deliver “the next shift between humans and computing” with series B funding from investors including Qualcomm and SoftBank.

Stanford-backed expense management platform Jeeves has received series B funding, two months after emerging from stealth.